About Incannex Healthcare Limited
https://www.incannex.com.auIncannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name.
CEO
Joel Bradley Latham
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-11-30 | Reverse | 1:4 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership
ARETE WEALTH ADVISORS, LLC
Shares:1.18M
Value:$458.12K
ADVISORSHARES INVESTMENTS LLC
Shares:471.28K
Value:$183.19K
VIRTU FINANCIAL LLC
Shares:402.44K
Value:$156.43K
Summary
Showing Top 3 of 29
About Incannex Healthcare Limited
https://www.incannex.com.auIncannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $66.62K ▲ | $15.77M ▲ | $-35.57M ▼ | -53.4K% ▼ | $-1.03 ▼ | $-39.05M ▼ |
| Q3-2025 | $0 ▼ | $8.36M ▲ | $-6.63M ▲ | 0% ▲ | $-0.2 ▲ | $-6.41M ▲ |
| Q2-2025 | $19.38K ▼ | $8.1M ▼ | $-9.52M ▼ | -49.12K% ▼ | $-0.33 ▼ | $-9.04M ▼ |
| Q1-2025 | $108.99K ▲ | $9.32M ▼ | $-7.98M ▲ | -7.32K% ▲ | $-0.29 ▲ | $-7.92M ▲ |
| Q4-2024 | $17.97K | $14.61M | $-9.67M | -53.84K% | $-0.38 | $-9.58M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $15.04M ▲ | $20.45M ▲ | $7.06M ▼ | $13.39M ▲ |
| Q2-2025 | $2.1M ▼ | $11.11M ▼ | $10.14M ▲ | $965K ▼ |
| Q4-2024 | $5.86M ▼ | $17.05M ▼ | $5.83M ▲ | $11.22M ▼ |
| Q2-2024 | $14.55M ▼ | $22.36M ▼ | $3.49M ▲ | $18.87M ▼ |
| Q4-2023 | $22.12M | $23.78M | $2.96M | $20.82M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-35.57M ▼ | $-4.64M ▲ | $62K ▲ | $17.35M ▲ | $12.94M ▲ | $-1.03M ▲ |
| Q2-2025 | $-5.89M ▲ | $-5.68M ▼ | $-8K ▼ | $4.1M ▲ | $-1.53M ▲ | $-7.88M ▼ |
| Q4-2024 | $-6.46M ▼ | $-3.64M ▼ | $-3K ▲ | $0 | $-3.45M ▼ | $-3.65M ▼ |
| Q2-2024 | $-5.24M ▼ | $-2.1M ▲ | $-59K ▲ | $0 ▲ | $-1.72M ▲ | $-2.16M ▲ |
| Q4-2023 | $-4.17M | $-2.58M | $-171K | $-32K | $-2.76M | $-2.75M |
CEO
Joel Bradley Latham
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-11-30 | Reverse | 1:4 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership
ARETE WEALTH ADVISORS, LLC
Shares:1.18M
Value:$458.12K
ADVISORSHARES INVESTMENTS LLC
Shares:471.28K
Value:$183.19K
VIRTU FINANCIAL LLC
Shares:402.44K
Value:$156.43K
Summary
Showing Top 3 of 29